详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

ACE2 expression and its implication in the association between COVID-19 and allergic rhinitis.

90| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China [2]Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China [3]Key Laboratory of Respiratory Diseases of Ministry of Health, Wuhan, China

出处：

DOI：

ISSN：

关键词： allergic rhinitis angiotensin-converting enzyme II coronavirus disease 2019 cytokine epithelial cell

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 1 区

医学

小类 | 2 区过敏 2 区免疫学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区过敏 1 区免疫学

JCR分区：

出版当年[2019]版：

Q1 IMMUNOLOGY Q1 ALLERGY

最新[2023]版：

Q1 ALLERGY Q1 IMMUNOLOGY

影响因子： 12.6 最新[2023版] 11.8 最新五年平均 8.706 出版当年[2019版] 7.466 出版当年五年平均 6.771 出版前一年[2018版] 13.146 出版后一年[2020版]

第一作者：

第一作者单位： [1]Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China

共同第一作者：

通讯作者：

通讯机构： [1]Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China [3]Key Laboratory of Respiratory Diseases of Ministry of Health, Wuhan, China [*1]Department of Otolaryngology-Head and Neck Surgery Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology No. 1095 Jiefang Avenue Wuhan 430030, P.R. China [*2]Department of Otolaryngology-Head and Neck Surgery Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology No. 1095 Jiefang Avenue Wuhan 430030, P.R. China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis. [2]Cytokine storm syndrome in coronavirus disease 2019: A narrative review [3]Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality [4]Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome [5]Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19 [6]Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)? [7]Coronavirus disease 2019: What we know? [8]Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial [9]Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study [10]Cardiovascular involvement in patients with 2019 novel coronavirus disease